HERON THERAPEUTICS, INC. /DE/ Other Income
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Other Income of -$197.00 thousand for the 3-month period ending 2012-12-31, per its 10-K filed 2013-03-01.
Discontinued › Income Statement › Other Income
us-gaap:OtherIncome · last filed 2013-03-01
- HERON THERAPEUTICS, INC. /DE/ other income for the quarter ending 2012-12-31 was -$197.00K.
- HERON THERAPEUTICS, INC. /DE/ other income for the quarter ending 2012-09-30 was -$195.00K.
- HERON THERAPEUTICS, INC. /DE/ other income for the quarter ending 2012-06-30 was -$146.00K.
- HERON THERAPEUTICS, INC. /DE/ other income for the quarter ending 2012-03-31 was -$61.00K.
- HERON THERAPEUTICS, INC. /DE/ other income for fiscal 2012 was -$599.00K.
- HERON THERAPEUTICS, INC. /DE/ other income for fiscal 2011 was -$373.00K, a 113.62% decline from fiscal 2010.
- HERON THERAPEUTICS, INC. /DE/ other income for fiscal 2010 was $2.74M, a 11308.33% increase from fiscal 2009.
- HERON THERAPEUTICS, INC. /DE/ other income for fiscal 2009 was $24.00K.
| Period end | Other Income 3 month | Other Income 6 month | Other Income 9 month | Other Income 12 month |
|---|---|---|---|---|
| 2012-12-31 | -$197.00K 10-K · filed 2013-03-01 | -$392.00K derived: sum of 2 quarters · filed 2013-03-01 | -$538.00K derived: sum of 3 quarters · filed 2013-03-01 | -$599.00K 10-K · filed 2013-03-01 |
| 2012-09-30 | -$195.00K 10-K · filed 2013-03-01 | -$341.00K derived: sum of 2 quarters · filed 2013-03-01 | -$402.00K derived: sum of 3 quarters · filed 2013-03-01 | -$449.00K derived: sum of 4 quarters · filed 2013-03-01 |
| 2012-06-30 | -$146.00K 10-K · filed 2013-03-01 | -$207.00K derived: sum of 2 quarters · filed 2013-03-01 | -$254.00K derived: sum of 3 quarters · filed 2013-03-01 | -$316.00K derived: sum of 4 quarters · filed 2013-03-01 |
| 2012-03-31 | -$61.00K 10-K · filed 2013-03-01 | -$108.00K derived: sum of 2 quarters · filed 2013-03-01 | -$170.00K derived: sum of 3 quarters · filed 2013-03-01 | -$433.00K derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-12-31 | -$47.00K 10-K · filed 2013-03-01 | -$109.00K derived: sum of 2 quarters · filed 2013-03-01 | -$372.00K derived: sum of 3 quarters · filed 2013-03-01 | -$373.00K 10-K · filed 2013-03-01 |
| 2011-09-30 | -$62.00K 10-K · filed 2013-03-01 | -$325.00K derived: sum of 2 quarters · filed 2013-03-01 | -$326.00K derived: sum of 3 quarters · filed 2013-03-01 | |
| 2011-06-30 | -$263.00K 10-K · filed 2013-03-01 | -$264.00K derived: sum of 2 quarters · filed 2013-03-01 | ||
| 2011-03-31 | -$1.00K 10-K · filed 2013-03-01 | |||
| 2010-12-31 | $2.74M 10-K · filed 2013-03-01 | |||
| 2009-12-31 | $24.00K 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |